(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.08%755.65B | 1.05%547.7B | 0.44%364.45B | 2.61%176.59B | 5.32%719.08B | 4.99%542B | 6.97%362.85B | 13.27%172.1B | 9.33%682.79B | 25.99%516.22B |
Operating income | 5.08%755.65B | 1.05%547.7B | 0.44%364.45B | 2.61%176.59B | 5.32%719.08B | 4.99%542B | 6.97%362.85B | 13.27%172.1B | 9.33%682.79B | 25.99%516.22B |
Cost of sales | -4.05%-661.12B | ---- | 0.10%-324.82B | ---- | -6.21%-635.39B | ---- | -7.95%-325.14B | ---- | -9.88%-598.26B | ---- |
Operating expenses | -4.05%-661.12B | -0.97%-486.02B | 0.10%-324.82B | -2.65%-156.05B | -6.21%-635.39B | -5.45%-481.37B | -7.95%-325.14B | -13.57%-152.03B | -9.88%-598.26B | -27.30%-456.49B |
Gross profit | 12.95%94.53B | 1.73%61.68B | 5.06%39.63B | 2.36%20.54B | -0.98%83.69B | 1.51%60.63B | -0.78%37.72B | 11.09%20.06B | 5.61%84.52B | 16.77%59.73B |
Selling expenses | -25.95%-2.54B | -29.20%-1.64B | -29.28%-958M | -54.69%-505.25M | -39.15%-2.02B | -20.31%-1.27B | -8.65%-741M | -4.82%-326.62M | -22.97%-1.45B | -48.18%-1.06B |
Administrative expenses | -7.81%-47.59B | -1.37%-12.21B | -3.10%-18.24B | 1.27%-4.26B | -2.98%-44.14B | 8.58%-12.05B | 3.50%-17.69B | 13.88%-4.31B | -5.62%-42.86B | -0.81%-13.18B |
Research and development expenses | ---- | -0.43%-17.24B | ---- | -11.75%-5.04B | ---- | -10.08%-17.17B | ---- | -29.14%-4.51B | ---- | -28.72%-15.6B |
Profit from asset sales | ---- | 116.27%359.55M | ---- | -86.35%11.9M | ---- | 152.40%166.25M | ---- | 640.12%87.16M | ---- | 40.77%65.87M |
Revaluation surplus | ---- | -1,003.46%-701.51M | ---- | -236.26%-46.84M | ---- | -47.96%77.65M | ---- | -41.61%34.38M | ---- | 144.65%149.21M |
-Changes in the fair value of other assets | ---- | -1,003.46%-701.51M | ---- | -236.26%-46.84M | ---- | -47.96%77.65M | ---- | -41.61%34.38M | ---- | 144.65%149.21M |
Impairment and provision | 18.84%-7.9B | 16.25%-2.92B | -2.08%-2.84B | -1,127.54%-472.43M | -40.15%-9.74B | -142.48%-3.49B | -72.61%-2.79B | -219.46%-38.49M | -27.47%-6.95B | 38.34%-1.44B |
-Other impairment is provision | 18.84%-7.9B | 16.25%-2.92B | -2.08%-2.84B | -1,127.54%-472.43M | -40.15%-9.74B | -142.48%-3.49B | -72.61%-2.79B | -219.46%-38.49M | -27.47%-6.95B | 38.34%-1.44B |
Special items of operating profit | -60.36%2.46B | -89.59%134.5M | -55.68%2.03B | 35.11%-268.77M | 386.13%6.2B | 452.50%1.29B | 326.80%4.57B | -406.00%-414.22M | -19.14%1.28B | -38.87%233.74M |
Adjustment items of operating profit | ---- | -200.00%-1 | ---- | ---- | ---- | --1 | ---- | ---- | ---- | ---- |
Operating profit | 14.57%38.96B | -1.01%26.18B | -6.92%19.61B | -4.25%9.54B | -1.56%34B | -4.13%26.45B | 14.16%21.07B | 11.72%9.97B | 0.40%34.54B | 25.06%27.59B |
Financing income | 12.08%23.9B | ---- | 29.63%11.04B | ---- | 45.94%21.32B | ---- | 22.54%8.52B | ---- | 41.77%14.61B | ---- |
Financing cost | -10.95%-24.31B | 42.75%-1.01B | -10.66%-11.49B | 45.19%-1.07B | -12.13%-21.91B | 62.67%-1.77B | -12.34%-10.39B | 4.07%-1.96B | -14.00%-19.54B | 29.10%-4.75B |
Share of profits of associates | 18.37%406M | ---- | 216.58%218M | ---- | -56.58%343M | ---- | -1,435.71%-187M | ---- | 356.65%790M | ---- |
Share of profit from joint venture company | -111.56%-1.41B | ---- | -14.40%-715M | ---- | -8.47%-666M | ---- | -129.78%-625M | ---- | 21.88%-614M | ---- |
Special items of earning before tax | ---- | -123.28%-14.12M | ---- | -16.36%30.5M | ---- | -74.52%60.64M | ---- | -49.67%36.46M | ---- | 136.38%237.98M |
Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---1 | ---- | ---- | ---- | ---- |
Earning before tax | 13.45%37.54B | 1.68%25.15B | 1.48%18.66B | 5.66%8.5B | 11.08%33.09B | 7.19%24.73B | 15.63%18.39B | 15.72%8.04B | 10.50%29.79B | 49.25%23.07B |
Tax | 10.12%-6.4B | 11.44%-4.42B | 19.70%-3.21B | 9.15%-1.56B | -20.06%-7.12B | -12.36%-4.99B | -34.26%-4B | -34.39%-1.72B | 19.10%-5.93B | -21.59%-4.44B |
After-tax profit from continuing operations | 19.91%31.14B | 5.00%20.73B | 7.37%15.45B | 9.68%6.94B | 8.85%25.97B | 5.96%19.74B | 11.33%14.39B | 11.52%6.33B | 21.55%23.86B | 57.81%18.63B |
Special items of earning after tax | ---- | ---1 | ---- | ---1 | ---- | ---- | ---- | ---- | ---- | ---- |
Adjustment items of earning after tax | ---- | --1 | ---- | --1 | ---- | ---- | ---- | ---- | ---- | ---- |
Earning after tax | 19.91%31.14B | 5.00%20.73B | 7.37%15.45B | 9.68%6.94B | 8.85%25.97B | 5.96%19.74B | 11.33%14.39B | 11.52%6.33B | 21.55%23.86B | 57.81%18.63B |
Minority profit | 11.52%6.41B | 14.75%4.49B | 28.11%3.1B | 10.03%1.36B | 4.26%5.75B | 6.53%3.91B | -4.69%2.42B | -8.46%1.23B | 74.70%5.51B | 111.34%3.67B |
Profit attributable to shareholders | 22.29%24.73B | 2.59%16.25B | 3.17%12.35B | 9.60%5.58B | 10.23%20.23B | 5.82%15.84B | 15.24%11.97B | 17.74%5.09B | 11.37%18.35B | 48.58%14.96B |
Basic earnings per share | 26.09%1.45 | 3.30%0.94 | 2.86%0.72 | 10.34%0.32 | 10.58%1.15 | 5.81%0.91 | 16.67%0.7 | 16.00%0.29 | 13.04%1.04 | 56.36%0.86 |
Diluted earnings per share | 26.09%1.45 | 3.30%0.94 | 2.86%0.72 | 10.34%0.32 | 10.58%1.15 | 5.81%0.91 | 16.67%0.7 | 16.00%0.29 | 13.04%1.04 | 56.36%0.86 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | -- | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data